A Clinical Study of SHR-5421 in Patients With Multiple Myeloma

NCT07652281 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: SHR-5421 for Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.